Novel 1-Benzyl-4-Piperidinamines that are Useful in the Treatment of COPD and Asthma
申请人:Hemmerling Martin
公开号:US20100081692A1
公开(公告)日:2010-04-01
The invention provides 1-benzyl-4-piperidinamines of the general formula (I), processes for their preparation, pharmaceutical compositions containing them and their use in therapy. The compounds are useful in the treatment of respiratory diseases such as chronic obstructive pulmonary disease and asthma. The compounds are inhibitors of the CCR1 receptor.
NOVEL 1 -BENZYL-4-PIPERIDINAMINES THAT ARE USEFUL IN THE TREATMENT OF COPD AND ASTHMA
申请人:AstraZeneca AB
公开号:EP1945613A1
公开(公告)日:2008-07-23
[EN] NOVEL 1 -BENZYL-4-PIPERIDINAMINES THAT ARE USEFUL IN THE TREATMENT OF COPD AND ASTHMA<br/>[FR] NOUVELLES 1-BENZYL-4-PIPÉRIDINAMINES POUVANT ÊTRE EMPLOYÉES DANS LE TRAITEMENT DE LA BPCO ET DE L'ASTHME
申请人:ASTRAZENECA AB
公开号:WO2007053082A1
公开(公告)日:2007-05-10
[EN] The invention provides 1 -benzyl- 4 -piperidinamines of the general formula (I), processes for their preparation, pharmaceutical compositions containing them and their use in therapy. The compounds are useful in the treatment of respiratory diseses such as chronic obstructive pulmonary disease and asthma. The compounds are inhibitors of the CCRl receptor. [FR] La présente invention concerne des 1-benzyl-4-pipéridinamines de formule générale (I), des procédés de synthèse desdits composés, des préparations pharmaceutiques les contenant et leur utilisation en thérapie. Les composés peuvent être employés dans le traitement de maladies respiratoires telles que la bronchopneumopathie chronique obstructive et l'asthme. Ces composés sont des inhibiteurs du récepteur CCR1.